A Phase 3, Multicenter, randomized, double-blind Study of the Efficacy and Safety of Rezafungin for Injection versus Intravenous Caspofungin Followed by Optional Oral Fluconazole Step-down in the Treatment of Subjects with Candidemia and /or Invasive Candidiasis (The ReSTORE Study).